-
Mon20May2019
-
Mon20May2019Thu23May2019
-
Tue21May2019Fri24May2019
-
Wed12Jun2019Sat15Jun2019
-
Wed03Jul2019Fri05Jul2019
-
Thu04Jul2019Sat06Jul2019
-
Thu18Jul2019Sat20Jul2019
-
Sat31Aug2019Wed04Sep2019
Latest News
US FDA approve SSO2 Therapy for the management of myocardial infarction
TherOx has received US FDA premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. A press release reports that SSO2 Therapy provides interventional cardiologists with...
Features
Manage the risk of complications in CTO-PCI
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains one of the most demanding challenges for an interventional cardiologist. Technological developments have improved...
Reconciling the contrasting findings on MitraClip, and implications for the management...
Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge repair (MitraClip, Abbott) for the management of functional mitral regurgitation (MR)...
Videos
Toby Rogers (Washington,DC, USA) tells Cardiovascular News that preliminary feasibility data from 12 patients reveals that use of a dedicated closure device for the aorta after transcaval TAVR has “eliminated” transcaval-related bleeding. Transcaval-related bleeding remains a lingering concern that...
(Visited 37,184 times, 2 visits today)
